Aspirin Resistance, True or False?
DOI:
https://doi.org/10.31661/gmj.v2i4.160Keywords:
Aspirin, Resistance, coronary artery disease, plateletReferences
Sezavar SH, Farahani B, Gholami S, Moradi M, Zarei M, Ganji M, Miri S, Khalili N, Kerman SR. Association of Aspirin Intake and Myocardial Infarction Size. GMJ. 2012;1(1):35-37
ACKERMAN, R.H., NEWMAN, K.L. Incomplete antiplatelet effects in patients on aspirin compounds (abstract). Ann Neurol. 1990; 28:224.
Hankey GJ, Eikelboom JW. Aspirin resistance. Lancet. 2006;18;367(9510):606-17.
Oliveira DC, Silva RF, Silva DJ, Lima VC. Aspirin resistance: fact or fiction? Arq Bras Cardiol. 2010; 95(3):e91-4.
Faraday N, Braunstein JB, Heldman AW, Bolton ED, Chiles KA, Gerstenblith G, Schulman SP. Prospective evaluation of the relationship between platelet-leukocyte conjugate formation and recurrent myocardial ischemia in patients with acute coronary syndromes. Platelets. 2004;15:9-14.
Schwartz KA, Schwartz DE, Ghosheh K, Reeves MJ, Barber K, DeFranco A. Compliance as a critical consideration in patients who appear to be resistant to aspirin after healing of myocardial infarction. Am J Cardiol. 2005; 95:973-5.
Kojuri J, Mahmoody Y, Zangbar Sabegh B, Jannati M, Mahboodi A, Khalili A. Dose-related effect of aspirin on laboratory-defined platelet aggregation and clinical outcome after coronary stenting. Cardiovasc Ther. 2010; 28(3):147-52.
Published
Issue
Section
License
Copyright (c) 2013 Galen Medical Journal
This work is licensed under a Creative Commons Attribution 4.0 International License.
